JP2021535147A5 - - Google Patents

Info

Publication number
JP2021535147A5
JP2021535147A5 JP2021510761A JP2021510761A JP2021535147A5 JP 2021535147 A5 JP2021535147 A5 JP 2021535147A5 JP 2021510761 A JP2021510761 A JP 2021510761A JP 2021510761 A JP2021510761 A JP 2021510761A JP 2021535147 A5 JP2021535147 A5 JP 2021535147A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
composition
acceptable salt
teeth
Prior art date
Application number
JP2021510761A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020047496A5 (https=
JP7437384B2 (ja
JP2021535147A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049195 external-priority patent/WO2020047496A1/en
Publication of JP2021535147A publication Critical patent/JP2021535147A/ja
Publication of JPWO2020047496A5 publication Critical patent/JPWO2020047496A5/ja
Publication of JP2021535147A5 publication Critical patent/JP2021535147A5/ja
Application granted granted Critical
Publication of JP7437384B2 publication Critical patent/JP7437384B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510761A 2018-08-31 2019-08-30 イソキノリンステロイド抱合体およびその使用 Active JP7437384B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862725941P 2018-08-31 2018-08-31
US62/725,941 2018-08-31
PCT/US2019/049195 WO2020047496A1 (en) 2018-08-31 2019-08-30 Isoquinoline-steroid conjugates and uses thereof

Publications (4)

Publication Number Publication Date
JP2021535147A JP2021535147A (ja) 2021-12-16
JPWO2020047496A5 JPWO2020047496A5 (https=) 2022-08-31
JP2021535147A5 true JP2021535147A5 (https=) 2022-08-31
JP7437384B2 JP7437384B2 (ja) 2024-02-22

Family

ID=69639319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021510761A Active JP7437384B2 (ja) 2018-08-31 2019-08-30 イソキノリンステロイド抱合体およびその使用

Country Status (10)

Country Link
US (2) US11059789B2 (https=)
EP (1) EP3843736A4 (https=)
JP (1) JP7437384B2 (https=)
KR (1) KR20210053301A (https=)
CN (1) CN112638386A (https=)
AU (2) AU2019328590B2 (https=)
BR (1) BR112021003613A2 (https=)
MX (1) MX2021002380A (https=)
SG (1) SG11202101517PA (https=)
WO (1) WO2020047496A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020047496A1 (en) 2018-08-31 2020-03-05 Aerie Pharmaceuticals, Inc. Isoquinoline-steroid conjugates and uses thereof
WO2021024041A1 (en) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Controlled release drug dimers
WO2021207486A1 (en) * 2020-04-08 2021-10-14 Aerie Pharmaceuticals, Inc. Treatments
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
WO2022232602A1 (en) * 2021-04-29 2022-11-03 Aerie Pharmaceuticals, Inc. Stable isoquinoline-corticosteroid conjugates and uses thereof
WO2023079362A1 (en) * 2021-11-03 2023-05-11 Ripple Therapeutics Corporation Processable compositions and use for the same
CN115340472B (zh) * 2022-09-19 2024-05-07 合肥工业大学 一种谷氨酸衍生物及其合成方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3193459A (en) 1955-07-01 1965-07-06 Upjohn Co Steroid hemisuccinate compositions and method for extemporaneous administration
WO2007008926A1 (en) * 2005-07-11 2007-01-18 Aerie Pharmaceuticals, Inc. Isoquinoline compounds
US8455513B2 (en) * 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
BRPI0807078A2 (pt) * 2007-02-05 2014-04-08 Nicox Sa Composto, e, formulação farmacêutica
US8450344B2 (en) * 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3053913B1 (en) * 2009-05-01 2018-03-07 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
MX2015011948A (es) * 2013-03-08 2015-12-09 Allergan Inc Antibioticos conjugados directamente relacionados con farmacos esteroides.
WO2014138425A1 (en) * 2013-03-08 2014-09-12 Allergan, Inc. Cyclosporine a-steroid conjugates
DK3811943T3 (da) * 2013-03-15 2023-04-03 Aerie Pharmaceuticals Inc Forbindelse til anvendelse til behandling af øjenlidelser
BR112019003232A2 (pt) * 2016-08-19 2019-06-18 Aerie Pharmaceuticals Inc compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção
WO2020047496A1 (en) 2018-08-31 2020-03-05 Aerie Pharmaceuticals, Inc. Isoquinoline-steroid conjugates and uses thereof

Similar Documents

Publication Publication Date Title
JP2021535147A5 (https=)
US11026899B2 (en) Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
CN114008035A (zh) 一种shp2磷酸酶变构抑制剂
JP2024133475A5 (https=)
JP2018109022A5 (https=)
JP2020075939A5 (https=)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
RU2014111069A (ru) Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение
JP2017510610A5 (https=)
JP2021530453A5 (https=)
JP2015505564A5 (https=)
JP2020534270A5 (https=)
JP2019515909A5 (https=)
JP2019508476A5 (https=)
CR20210043A (es) Forma de dosificación farmacèutica administrable por vía oral con liberación modificada
JPWO2021187548A5 (https=)
JP2014148552A5 (https=)
JP2019524888A5 (https=)
JPWO2020047496A5 (https=)
JP2018529747A5 (https=)
JPWO2020006233A5 (https=)
JP2013507382A5 (https=)
JP2021511352A5 (https=)
JP2016539148A5 (https=)
JP2021525758A5 (https=)